Activity of trametinib as maintenance therapy after allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory RAS pathway-mutated hematologic malignancies

被引：0

作者：

Li, Zhihui ^{[1
]}

Yang, Keyan ^{[2
]}

Xu, Teng ^{[3
]}

Wang, Lei ^{[1
]}

Wang, Xianxuan ^{[1
]}

Wen, Xiaopei ^{[1
]}

Zhang, Caiyan ^{[2
]}

Wang, Jingjing ^{[1
]}

Zheng, Xiaoyu ^{[1
]}

Wu, Tong ^{[1
]}

Zheng, Qinlong ^{[2
]}

机构：

[1] Beijing Gaobo Boren Hosp, Dept Bone Marrow Transplantat, Beijing, Peoples R China

[2] Beijing Gaobo Boren Hosp, Dept Med Lab, Beijing, Peoples R China

[3] Beijing Gaobo Boren Hosp, Int Operat Dept, Beijing, Peoples R China

来源：

ANNALS OF HEMATOLOGY | 2024年

关键词：

ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; CREB-BINDING PROTEIN; MUTATIONS; P300; KRAS; NRAS;

D O I：

10.1007/s00277-024-06046-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1295 / 1301

页数：7

共 27 条

[1] CREB-binding protein and p300: molecular integrators of hematopoietic transcription [J].

Blobel, GA .

BLOOD, 2000, 95 (03) :745-755

[2] Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignancies [J].

Borthakur, Gautam ;

Popplewell, Leslie ;

Boyiadzis, Michael ;

Foran, James ;

Platzbecker, Uwe ;

Vey, Norbert ;

Walter, Roland B. ;

Olin, Rebecca ;

Raza, Azra ;

Giagounidis, Aristoteles ;

Al-Kali, Aref ;

Jabbour, Elias ;

Kadia, Tapan ;

Garcia-Manero, Guillermo ;

Bauman, John W. ;

Wu, Yuehui ;

Liu, Yuan ;

Schramek, Dan ;

Cox, Donna S. ;

Wissel, Paul ;

Kantarjian, Hagop .

CANCER, 2016, 122 (12) :1871-1879

[3] MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road [J].

Caunt, Christopher J. ;

Sale, Matthew J. ;

Smith, Paul D. ;

Cook, Simon J. .

NATURE REVIEWS CANCER, 2015, 15 (10) :577-592

[4] RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia [J].

Decroocq, Justine ;

Birsen, Rudy ;

Montersino, Camille ;

Chaskar, Prasad ;

Mano, Jordi ;

Poulain, Laury ;

Friedrich, Chloe ;

Alary, Anne-Sophie ;

Guermouche, Helene ;

Sahal, Ambrine ;

Fouquet, Guillemette ;

Gotanegre, Mathilde ;

Simonetta, Federico ;

Mouche, Sarah ;

Gestraud, Pierre ;

Lescure, Auriane ;

Del Nery, Elaine ;

Bosc, Claudie ;

Grenier, Adrien ;

Mazed, Fetta ;

Mondesir, Johanna ;

Chapuis, Nicolas ;

Ho, Liza ;

Boughalem, Aicha ;

Lelorc'h, Marc ;

Gobeaux, Camille ;

Fontenay, Michaela ;

Recher, Christian ;

Vey, Norbert ;

Guille, Arnaud ;

Birnbaum, Daniel ;

Hermine, Olivier ;

Radford-Weiss, Isabelle ;

Tsantoulis, Petros ;

Collette, Yves ;

Castellano, Remy ;

Sarry, Jean-Emmanuel ;

Pasmant, Eric ;

Bouscary, Didier ;

Kosmider, Olivier ;

Tamburini, Jerome .

LEUKEMIA, 2022, 36 (05) :1237-1252

[5] A Phase II Study of Azacitidine, Venetoclax, and Trametinib in Relapsed or Refractory Acute Myeloid Leukemia Harboring RAS Pathway-Activating Mutations [J].

Desikan, Sai Prasad ;

Ravandi, Farhad ;

Pemmaraju, Naveen ;

Konopleva, Marina ;

Loghavi, Sanam ;

Jabbour, Elias J. ;

Daver, Naval ;

Jain, Nitin ;

Chien, Kelly S. ;

Maiti, Abhishek ;

Montalban-Bravo, Guillermo ;

Kadia, Tapan M. ;

Macaron, Walid ;

DeLumpa, Ricardo ;

Kwari, Monica ;

Borthakur, Gautam ;

Short, Nicholas J. .

ACTA HAEMATOLOGICA, 2022, 145 (05) :529-536

[6] CREBBP knockdown enhances RAS/RAF/MEK/ERK signaling in Ras pathway mutated acute lymphoblastic leukemia but does not modulate chemotherapeutic response [J].

Dixon, Zach A. ;

Nicholson, Lindsay ;

Zeppetzauer, Martin ;

Matheson, Elizabeth ;

Sinclair, Paul ;

Harrison, Christine J. ;

Irving, Julie A. E. .

HAEMATOLOGICA, 2017, 102 (04) :736-745

[7] Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure [J].

Duval, Michel ;

Klein, John P. ;

He, Wensheng ;

Cahn, Jean-Yves ;

Cairo, Mitchell ;

Camitta, Bruce M. ;

Kamble, Rammurti ;

Copelan, Edward ;

de Lima, Marcos ;

Gupta, Vikas ;

Keating, Armand ;

Lazarus, Hillard M. ;

Litzow, Mark R. ;

Marks, David I. ;

Maziarz, Richard T. ;

Rizzieri, David A. ;

Schiller, Gary ;

Schultz, Kirk R. ;

Tallman, Martin S. ;

Weisdorf, Daniel .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (23) :3730-3738

[8] Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia [J].

Greil, C. ;

Engelhardt, M. ;

Ihorst, G. ;

Duque-Afonso, J. ;

Shoumariyeh, K. ;

Bertz, H. ;

Marks, R. ;

Zeiser, R. ;

Duyster, J. ;

Finke, J. ;

Wasch, R. .

BONE MARROW TRANSPLANTATION, 2021, 56 (04) :841-852

[9] Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation [J].

Jongmans, Marjolijn C. J. ;

van der Burgt, Ineke ;

Hoogerbrugge, Peter M. ;

Noordam, Kees ;

Yntema, Helger G. ;

Nillesen, Willy M. ;

Kuiper, Roland P. ;

Ligtenberg, Marjolijn J. L. ;

van Kessel, Ad Geurts ;

van Krieken, J. Han J. M. ;

Kiemeney, Lambertus A. L. M. ;

Hoogerbrugge, Nicoline .

EUROPEAN JOURNAL OF HUMAN GENETICS, 2011, 19 (08) :870-874

[10] Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure [J].

Jovein, Miriam Mozaffari ;

Ihorst, Gabriele ;

Duque-Afonso, Jesus ;

Waesch, Ralph ;

Bertz, Hartmut ;

Wehr, Claudia ;

Duyster, Justus ;

Zeiser, Robert ;

Finke, Juergen ;

Scherer, Florian .

BLOOD CANCER JOURNAL, 2023, 13 (01)

← 1 2 3 →